Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease

β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ deposition accelerates gray matter atrophy at early stages of the disease even before objective cognitive impairment is manifested. Identification of at-risk individuals at the presymptomatic stage has become a major research...

Full description

Saved in:
Bibliographic Details
Published inJAMA neurology Vol. 70; no. 7; p. 903
Main Authors Doré, Vincent, Villemagne, Victor L, Bourgeat, Pierrick, Fripp, Jurgen, Acosta, Oscar, Chetélat, Gael, Zhou, Luping, Martins, Ralph, Ellis, Kathryn A, Masters, Colin L, Ames, David, Salvado, Oliver, Rowe, Christopher C
Format Journal Article
LanguageEnglish
Published United States 01.07.2013
Subjects
Online AccessGet more information

Cover

Loading…
Abstract β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ deposition accelerates gray matter atrophy at early stages of the disease even before objective cognitive impairment is manifested. Identification of at-risk individuals at the presymptomatic stage has become a major research interest because it will allow early therapeutic interventions before irreversible synaptic and neuronal loss occur. We aimed to further characterize the cross-sectional and longitudinal relationship between Aβ deposition, gray matter atrophy, and cognitive impairment. To investigate the topographical relationship of Aβ deposition, gray matter atrophy, and memory impairment in asymptomatic individuals with Alzheimer disease pathology as assessed by Pittsburgh compound B positron emission tomography (PiB-PET). Regional analysis was performed on the cortical surface to relate cortical thickness to PiB retention and episodic memory. The Australian Imaging, Biomarkers, and Lifestyle Study of Aging, Austin Hospital, Melbourne, Australia. Ninety-three healthy elderly control subjects (NCs) and 40 patients with Alzheimer disease from the Australian Imaging, Biomarkers, and Lifestyle Study of Aging cohort. Participants underwent neuropsychological evaluation as well as magnetic resonance imaging and PiB-PET scans. Fifty-four NCs underwent repeated scans and neuropsychological evaluation 18 and 36 months later. Correlations between cortical thickness, PiB retention, and episodic memory. RESULTS There was a significant reduction in cortical thickness in the precuneus and hippocampus associated with episodic memory impairment in the NC PiB-positive (NC+) group when compared with the NC- group. Cortical thickness was also correlated negatively with neocortical PiB in the NC+ group. Longitudinal analysis showed a faster rate of gray matter (GM) atrophy in the temporal lobe and the hippocampi of the NC+ group. Over time, GM atrophy became more extensive in the NC+ group, especially in the temporal lobe. In asymptomatic individuals, Aβ deposition is associated with GM atrophy and memory impairment. The earliest signs of GM atrophy were detected in the hippocampus and the posterior cingulate and precuneus regions, and with disease progression, atrophy became more extensive in the temporal lobes. These findings support the notion that Aβ deposition is not a benign process and that interventions with anti-Aβ therapy at these early stages have a higher chance to be effective.
AbstractList β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ deposition accelerates gray matter atrophy at early stages of the disease even before objective cognitive impairment is manifested. Identification of at-risk individuals at the presymptomatic stage has become a major research interest because it will allow early therapeutic interventions before irreversible synaptic and neuronal loss occur. We aimed to further characterize the cross-sectional and longitudinal relationship between Aβ deposition, gray matter atrophy, and cognitive impairment. To investigate the topographical relationship of Aβ deposition, gray matter atrophy, and memory impairment in asymptomatic individuals with Alzheimer disease pathology as assessed by Pittsburgh compound B positron emission tomography (PiB-PET). Regional analysis was performed on the cortical surface to relate cortical thickness to PiB retention and episodic memory. The Australian Imaging, Biomarkers, and Lifestyle Study of Aging, Austin Hospital, Melbourne, Australia. Ninety-three healthy elderly control subjects (NCs) and 40 patients with Alzheimer disease from the Australian Imaging, Biomarkers, and Lifestyle Study of Aging cohort. Participants underwent neuropsychological evaluation as well as magnetic resonance imaging and PiB-PET scans. Fifty-four NCs underwent repeated scans and neuropsychological evaluation 18 and 36 months later. Correlations between cortical thickness, PiB retention, and episodic memory. RESULTS There was a significant reduction in cortical thickness in the precuneus and hippocampus associated with episodic memory impairment in the NC PiB-positive (NC+) group when compared with the NC- group. Cortical thickness was also correlated negatively with neocortical PiB in the NC+ group. Longitudinal analysis showed a faster rate of gray matter (GM) atrophy in the temporal lobe and the hippocampi of the NC+ group. Over time, GM atrophy became more extensive in the NC+ group, especially in the temporal lobe. In asymptomatic individuals, Aβ deposition is associated with GM atrophy and memory impairment. The earliest signs of GM atrophy were detected in the hippocampus and the posterior cingulate and precuneus regions, and with disease progression, atrophy became more extensive in the temporal lobes. These findings support the notion that Aβ deposition is not a benign process and that interventions with anti-Aβ therapy at these early stages have a higher chance to be effective.
Author Doré, Vincent
Bourgeat, Pierrick
Acosta, Oscar
Masters, Colin L
Fripp, Jurgen
Chetélat, Gael
Martins, Ralph
Rowe, Christopher C
Zhou, Luping
Ames, David
Salvado, Oliver
Ellis, Kathryn A
Villemagne, Victor L
Author_xml – sequence: 1
  givenname: Vincent
  surname: Doré
  fullname: Doré, Vincent
  email: vincent.dore@csiro.au
  organization: CSIRO Preventative Health National Research Flagship ICTC, the Australian e-Health Research Centre-BioMedical, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. vincent.dore@csiro.au
– sequence: 2
  givenname: Victor L
  surname: Villemagne
  fullname: Villemagne, Victor L
– sequence: 3
  givenname: Pierrick
  surname: Bourgeat
  fullname: Bourgeat, Pierrick
– sequence: 4
  givenname: Jurgen
  surname: Fripp
  fullname: Fripp, Jurgen
– sequence: 5
  givenname: Oscar
  surname: Acosta
  fullname: Acosta, Oscar
– sequence: 6
  givenname: Gael
  surname: Chetélat
  fullname: Chetélat, Gael
– sequence: 7
  givenname: Luping
  surname: Zhou
  fullname: Zhou, Luping
– sequence: 8
  givenname: Ralph
  surname: Martins
  fullname: Martins, Ralph
– sequence: 9
  givenname: Kathryn A
  surname: Ellis
  fullname: Ellis, Kathryn A
– sequence: 10
  givenname: Colin L
  surname: Masters
  fullname: Masters, Colin L
– sequence: 11
  givenname: David
  surname: Ames
  fullname: Ames, David
– sequence: 12
  givenname: Oliver
  surname: Salvado
  fullname: Salvado, Oliver
– sequence: 13
  givenname: Christopher C
  surname: Rowe
  fullname: Rowe, Christopher C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23712469$$D View this record in MEDLINE/PubMed
BookMark eNo1kE1OwzAUhC0EoqX0Bgj5AE2xncROl1XFn1SJDawrx35pXBI7spOicCy4B2cibeFtnjTzzSzmCp1bZwGhG0rmlBB6t5O1tNB5V80ZofEgcnaGxozyLOI0FSM0DWFHhssISeLkEo1YLChL-GKMvlfehRAFUK1xVlZYWo0rZ7em7bQ5CbLqgwnYFbgtAXuo5IENpWlwDu0HgMXLny-soXHBHKwZVs63Rg3ptjTq3UIIs2NzDbXzPTZ2ILZ2gPdQ9bizpm6k8aAHR5u90Z2swjEwkMvqswRTg8faBJABrtFFMfgw_fsT9PZw_7p6itYvj8-r5TqSMeNtxGOSaC2yJI_5YkEUFCmPtSC5LBgtBIi0UCpLodCpoooKmUouIWUqBRAiX7AJuj31Nl1eg9403tTS95v_9dgvlx17yQ
CitedBy_id crossref_primary_10_1007_s10072_020_04864_x
crossref_primary_10_3389_fendo_2019_00217
crossref_primary_10_1007_s00259_021_05191_9
crossref_primary_10_1038_s41598_017_06876_8
crossref_primary_10_1016_j_ebiom_2022_104336
crossref_primary_10_1016_j_tics_2013_08_007
crossref_primary_10_3233_JAD_171145
crossref_primary_10_1016_j_neurobiolaging_2017_09_009
crossref_primary_10_1016_j_neurobiolaging_2019_07_005
crossref_primary_10_3390_molecules200813496
crossref_primary_10_1016_j_trci_2017_09_003
crossref_primary_10_1586_14737175_2015_1023296
crossref_primary_10_1016_j_neurobiolaging_2019_02_018
crossref_primary_10_3389_fnins_2023_1275932
crossref_primary_10_1093_brain_awy044
crossref_primary_10_1016_j_jalz_2017_09_013
crossref_primary_10_1002_dad2_12556
crossref_primary_10_1016_j_neuron_2014_10_038
crossref_primary_10_1002_jmri_26810
crossref_primary_10_1097_MD_0000000000000150
crossref_primary_10_1016_j_nicl_2023_103409
crossref_primary_10_1016_j_nicl_2017_10_034
crossref_primary_10_1080_13854046_2023_2184720
crossref_primary_10_3233_JAD_161173
crossref_primary_10_1016_j_neurobiolaging_2017_10_023
crossref_primary_10_1590_0004_282x_anp_2022_s138
crossref_primary_10_1007_s11065_014_9267_4
crossref_primary_10_1016_j_jalz_2016_02_002
crossref_primary_10_1007_s11682_018_9888_y
crossref_primary_10_2139_ssrn_4121648
crossref_primary_10_1002_dad2_12022
crossref_primary_10_2217_bmm_13_98
crossref_primary_10_1002_jnr_24739
crossref_primary_10_1016_j_jamda_2016_06_017
crossref_primary_10_3389_fnana_2014_00019
crossref_primary_10_1016_j_jcmg_2014_09_018
crossref_primary_10_1371_journal_pone_0224030
crossref_primary_10_1038_s41598_019_39809_8
crossref_primary_10_1038_s41598_019_47638_y
crossref_primary_10_1016_j_neurobiolaging_2023_05_009
crossref_primary_10_1371_journal_pone_0152983
crossref_primary_10_1016_j_neurobiolaging_2015_06_027
crossref_primary_10_1093_brain_awv326
crossref_primary_10_1097_RLU_0000000000001147
crossref_primary_10_3233_JAD_179928
crossref_primary_10_3389_fnagi_2022_1054516
crossref_primary_10_1017_S1355617716000813
crossref_primary_10_1093_braincomms_fcad192
crossref_primary_10_1007_s11682_013_9278_4
crossref_primary_10_1016_j_dadm_2018_08_007
crossref_primary_10_1007_s12603_014_0507_3
crossref_primary_10_1016_j_jalz_2014_11_002
crossref_primary_10_1016_j_neuroscience_2014_11_063
crossref_primary_10_1038_s41598_024_74262_2
crossref_primary_10_1016_j_trci_2018_04_007
crossref_primary_10_1016_j_jalz_2016_06_2365
crossref_primary_10_3233_JAD_230030
crossref_primary_10_3233_JAD_231362
crossref_primary_10_1002_alz_13083
crossref_primary_10_1093_brain_aww200
crossref_primary_10_3389_fnagi_2018_00325
crossref_primary_10_1016_j_neuint_2022_105401
crossref_primary_10_3233_JAD_170720
crossref_primary_10_1002_hbm_26532
crossref_primary_10_3389_fnimg_2022_828767
crossref_primary_10_3233_JAD_170448
crossref_primary_10_1002_brb3_1601
crossref_primary_10_1007_s12603_014_0485_5
crossref_primary_10_1016_j_arr_2016_01_002
crossref_primary_10_1093_gerona_glad114
crossref_primary_10_1142_S0129065716500039
crossref_primary_10_3233_JAD_220249
crossref_primary_10_1007_s11682_021_00558_w
crossref_primary_10_3233_ADR_210005
crossref_primary_10_1016_j_bbr_2021_113387
crossref_primary_10_1038_nrneurol_2018_9
crossref_primary_10_1093_arclin_acu068
crossref_primary_10_1093_braincomms_fcae451
crossref_primary_10_1016_j_neurobiolaging_2018_01_017
crossref_primary_10_7554_eLife_77745
crossref_primary_10_1007_s10072_018_3620_y
crossref_primary_10_2967_jnmt_123_265568
crossref_primary_10_1177_13872877251316801
crossref_primary_10_3390_brainsci13040631
crossref_primary_10_1186_s12877_020_1423_5
crossref_primary_10_1093_cercor_bhx099
crossref_primary_10_1186_s13195_014_0062_5
crossref_primary_10_3389_fnagi_2024_1356656
crossref_primary_10_1007_s40263_019_00613_7
crossref_primary_10_1002_brb3_2837
crossref_primary_10_1016_j_dadm_2015_11_003
crossref_primary_10_1097_MNM_0000000000001042
crossref_primary_10_1016_j_nicl_2018_04_016
crossref_primary_10_3233_JAD_160327
crossref_primary_10_3233_JAD_170261
crossref_primary_10_1007_s00429_019_01915_8
crossref_primary_10_3233_JAD_150877
crossref_primary_10_1016_j_jalz_2016_08_010
crossref_primary_10_1590_1980_57642021dn15_030002
crossref_primary_10_1016_j_neurobiolaging_2016_06_003
crossref_primary_10_1038_s41583_018_0067_3
crossref_primary_10_1038_s41598_018_20513_y
crossref_primary_10_1002_acn3_51273
crossref_primary_10_1007_s00259_019_04446_w
crossref_primary_10_1111_joa_12155
crossref_primary_10_1016_j_jpsychires_2017_02_019
crossref_primary_10_1016_j_jalz_2014_04_513
crossref_primary_10_1007_s13346_021_00940_7
crossref_primary_10_3233_JAD_201133
crossref_primary_10_1002_hbm_23719
crossref_primary_10_1016_j_nicl_2016_06_010
crossref_primary_10_1016_j_nicl_2017_01_026
crossref_primary_10_12779_dnd_2019_18_4_113
crossref_primary_10_1016_j_neurobiolaging_2018_11_005
crossref_primary_10_1007_s00259_014_2704_z
crossref_primary_10_1016_j_dadm_2015_01_003
crossref_primary_10_3389_fonc_2020_573512
crossref_primary_10_1016_j_yebeh_2020_107278
crossref_primary_10_1002_alz_14415
crossref_primary_10_3233_ADR_230027
crossref_primary_10_1002_hbm_24799
crossref_primary_10_1016_j_jalz_2015_03_002
crossref_primary_10_1053_j_semnuclmed_2016_09_006
crossref_primary_10_1159_000526297
crossref_primary_10_1038_s41598_017_09577_4
crossref_primary_10_1002_mds_26590
crossref_primary_10_1111_ene_15241
crossref_primary_10_1002_dad2_12291
crossref_primary_10_1038_s41598_018_21983_w
crossref_primary_10_1093_brain_aww193
crossref_primary_10_3389_fneur_2020_00053
crossref_primary_10_1002_alz_13576
crossref_primary_10_1016_j_jhazmat_2024_134756
crossref_primary_10_1016_j_cnp_2018_06_001
crossref_primary_10_3390_jimaging8040103
crossref_primary_10_1002_sim_8568
crossref_primary_10_1080_23279095_2019_1710509
crossref_primary_10_1002_dad2_12288
crossref_primary_10_61186_nl_3_3_19
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1001/jamaneurol.2013.1062
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6157
ExternalDocumentID 23712469
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID 0R~
4.4
53G
AAGZG
ABIVO
ABJNI
ACDNT
ACGFS
ACPRK
ADBBV
ADHGD
AENEX
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
EX3
H13
NPM
OB2
OBH
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
ID FETCH-LOGICAL-a326t-6304dd784b36990cef563d70baf21f7e75fcc85efd5c1c17a5a6ae52c5ee77b92
IngestDate Thu Apr 03 07:00:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a326t-6304dd784b36990cef563d70baf21f7e75fcc85efd5c1c17a5a6ae52c5ee77b92
PMID 23712469
ParticipantIDs pubmed_primary_23712469
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA neurology
PublicationTitleAlternate JAMA Neurol
PublicationYear 2013
SSID ssj0000800434
Score 2.4893458
Snippet β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ deposition accelerates gray matter atrophy at early stages of the disease even...
SourceID pubmed
SourceType Index Database
StartPage 903
SubjectTerms Aged
Aged, 80 and over
Aging - metabolism
Aging - pathology
Aging - physiology
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer Disease - physiopathology
Amyloid beta-Peptides - metabolism
Atrophy
Cerebral Cortex - metabolism
Cerebral Cortex - pathology
Cerebral Cortex - physiopathology
Cross-Sectional Studies
Female
Humans
Longitudinal Studies
Magnetic Resonance Imaging - instrumentation
Magnetic Resonance Imaging - methods
Male
Memory Disorders - metabolism
Memory Disorders - pathology
Memory Disorders - physiopathology
Memory, Episodic
Positron-Emission Tomography
Prodromal Symptoms
Title Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
URI https://www.ncbi.nlm.nih.gov/pubmed/23712469
Volume 70
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELa6ICEuiH9YfuQDe-oGNbYTu8du2dUKaTntor2tHMeBQJtU2vbAPtbyHrwGr8GM7SRW-RFwiSq7jZrMp_GM_X0zhLzS3CgFCU7CuGAJrNcmUSU4QylLLSCTs8qVFDp5lx-fibfn2flo9D1iLW3WxWtz9Utdyf9YFcbArqiS_QfL9jeFAfgM9oUrWBiuf2XjOS5xyaVjUzVB9L9osQPRpqz9wFByxHEJO-pbTNGa7c0P9w4YkmIDgwvfO2SlfpsbCfGf0SF2RM8lknOdXLDnHi2-jDcNCi5rpLPXvcjrMhR3Gs8WVx9tvcR25NGJUBcUg-Mfu8Ka8Rb_mzac4jsqbt2YiKLzHhWMS_0h8HRrPHkY99vYBy1qvbXnH9dYetL0eqQjcJIrL0dB2Wm86YENKGS36WGdc2RpriDt9cWtO0_uW5AExMrILU9dHYWfl4uhTYF_SKT6cRj2C0SEoNXSQYhxCfGQ7y3z59mtIt7d1A7ZgXQG-7OGTaVPIWgXXPTCTl8Ta_sfYdnqcJetFMiFQqd3yZ2Qw9CZB-Q9MrLNfXLrJLA0HpCvW7ikAAIa45J2uKRtRQGXNMYlDbiks2_XdMDkPu0QSXtE7rs7ezzSuqERHumARxrh0f0AvtnjkQY8PiRnR4en8-MkNAdJNGQc6yTnE1GWUomC5xBRGVtlOS_lpNAVSytpZVYZozJblZlJTSp1pnNtM2Yya6UspuwRudG0jX1C6EQZLrgtuFaVUDkv9BTi2FSkdmrSyrKn5LF_3RcrXwHmojPE7m9nnpHbA26fk5sVPKJ9AfHrunjprP8DUDGmFA
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-sectional+and+longitudinal+analysis+of+the+relationship+between+A%CE%B2+deposition%2C+cortical+thickness%2C+and+memory+in+cognitively+unimpaired+individuals+and+in+Alzheimer+disease&rft.jtitle=JAMA+neurology&rft.au=Dor%C3%A9%2C+Vincent&rft.au=Villemagne%2C+Victor+L&rft.au=Bourgeat%2C+Pierrick&rft.au=Fripp%2C+Jurgen&rft.date=2013-07-01&rft.eissn=2168-6157&rft.volume=70&rft.issue=7&rft.spage=903&rft_id=info:doi/10.1001%2Fjamaneurol.2013.1062&rft_id=info%3Apmid%2F23712469&rft_id=info%3Apmid%2F23712469&rft.externalDocID=23712469